1. Analysis of gene expression and methylation datasets identified ADAMTS9, FKBP5, and PFKBF3 as biomarkers for osteoarthritis
   ZhaoFang Li et al, 2019, Journal of Cellular Physiology CrossRef
2. ADAM and ADAMTS Family of Metalloproteinases: Role in Cancer Progression and Acquisition of Hallmarks
   Rajakishore Mishra et al, 2017, Proteases in Human Diseases CrossRef
3. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers
   Felix Kordowski et al, 2018, BMC Cancer CrossRef
4. The mechanistic role of epigenetic in multiple myeloma
   Saeideh Hajizamani et al, 2016, Comparative Clinical Pathology CrossRef
5. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer
   Malin Lando et al, 2015, Epigenetics CrossRef
6. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer
   Bianfei Shao et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
7. The use of pan-cancer analysis ofADAMTS9expression in various cancer types
   Shijun Jiang et al, 2021, Epigenomics CrossRef
8. DNMT3A-mediated silence in ADAMTS9 expression is restored by RNF180 to inhibit viability and motility in gastric cancer cells
   Weilin Sun et al, 2021, Cell Death & Disease CrossRef
9. ADAMTS9-AS1 inhibits tumor growth and drug resistance in clear cell renal cell carcinoma via recruiting HuR to enhance ADAMTS9 mRNA stability
   Enyang Zhao et al, 2023, Cancer Nanotechnology CrossRef
10. Adaptive sequence convergence of the tumor suppressor ADAMTS9 between small-bodied mammals displaying exceptional longevity
    Matthew J. Lambert et al, 2017, Aging CrossRef
11. ADAMTS proteases and cancer
    Santiago Cal et al, 2015, Matrix Biology CrossRef